Saxenda, also effective in treating obesity in children aged 6 to 12
Saxenda (Photo = provided by Novo Nordisk) (Health Korea News / Yu Ji-in) Novo Nordisk’s Saxenda (ingredient name: Liraglutide) was found to be effective in treating obesity in children aged 6 to 12. Novo Nordisk announced the results of a … Read more